EndoGastric Solutions Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:EndoGastric Solutions Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6467
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EndoGastric Solutions Inc (EGS), formerly EsophyX Inc, is a medical device company that manufactures and markets gastroenterology and surgical products for the treatment of gastroesophageal reflux disease (GERD). The company’s products comprise esophyX device and Serosa-Fuse fasteners. Its technology platform, the esophyX fastener delivery system, rebuilds the gastroesophageal valve and reinstates its function as a barrier, preventing stomach acid reflux. The esophyX device is used in Transoral Incisionless Fundoplication (TIF) procedure, which combines the latest developments in gastroenterology and surgery, provides a surgical solution without the need for external incisions. The company’s Serosa-Fuse fasteners are deployed using EsophyX devices to turn esophagogastric tissue into pleats. The fasteners reduce local inflammation and facilitate GI tissue repair naturally. EGS is headquartered in Redmond, Washington, the US.

EndoGastric Solutions Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EndoGastric Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EndoGastric Solutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EndoGastric Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EndoGastric Solutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
EndoGastric Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EndoGastric Solutions Inc, Medical Equipment, Deal Details 11
Venture Financing 11
EndoGastric Solutions Raises USD30.5 Million in Financing 11
EndoGastric Solutions Raises USD50 Million in Financing Round 13
Endogastric Solutions Raises USD10 Million in Venture Financing 15
Endogastric Solutions Raises USD1.3 Million in Venture Financing 16
Endogastric Solutions Raises US$30 Million In Series G Venture Financing 17
Endogastric Solutions Raises US$1 Million In Venture Financing 19
Endogastric Solutions Raises US$10 Million In Venture Financing 20
EndoGastric Solutions Raises Additional US$13 Million In Series F Financing 21
Endogastric Solutions Raises US$10.9 Million In Series G Financing 23
EndoGastric Solutions Inc – Key Competitors 24
EndoGastric Solutions Inc – Key Employees 25
EndoGastric Solutions Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Corporate Communications 27
Jul 24, 2017: EndoGastric Solutions Expands Commercial Leadership Team to Meet Increased Demand for TIF Procedure for Reflux 27
Product News 28
May 31, 2018: EndoGastric Solutions Announces Publication of Meta-Analysis Further Validating TIF 2.0 procedure as an Appropriate Treatment Option for Refractory GERD Patients 28
Sep 06, 2017: EndoGastric Solutions Announces the Presentation of 4 Year TEMPO Data Confirming Long-term Control of Chronic GERD Symptoms with TIF procedure 29
Other Significant Developments 30
Aug 24, 2017: EndoGastric Solutions announces Coverage Verification by HealthNet for TIF 2.0 Procedure with EsophyX Device 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
EndoGastric Solutions Inc, Medical Equipment, Key Facts 2
EndoGastric Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
EndoGastric Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EndoGastric Solutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EndoGastric Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EndoGastric Solutions Inc, Deals By Market, 2012 to YTD 2018 8
EndoGastric Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EndoGastric Solutions Raises USD30.5 Million in Financing 11
EndoGastric Solutions Raises USD50 Million in Financing Round 13
Endogastric Solutions Raises USD10 Million in Venture Financing 15
Endogastric Solutions Raises USD1.3 Million in Venture Financing 16
Endogastric Solutions Raises US$30 Million In Series G Venture Financing 17
Endogastric Solutions Raises US$1 Million In Venture Financing 19
Endogastric Solutions Raises US$10 Million In Venture Financing 20
EndoGastric Solutions Raises Additional US$13 Million In Series F Financing 21
Endogastric Solutions Raises US$10.9 Million In Series G Financing 23
EndoGastric Solutions Inc, Key Competitors 24
EndoGastric Solutions Inc, Key Employees 25

List of Figures
EndoGastric Solutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
EndoGastric Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
EndoGastric Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
EndoGastric Solutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
EndoGastric Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EndoGastric Solutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
EndoGastric Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EndoGastric Solutions Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[EndoGastric Solutions Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • American Armed Forces Mutual Aid Association:企業の戦略的SWOT分析
    American Armed Forces Mutual Aid Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Exterran Corp (EXTN):石油・ガス:M&Aディール及び事業提携情報
    Summary Exterran Corp (Exterran) is an energy service company that provides compression, production and processing products; and offers services that support the production and transportation of oil and natural gas. The company owns and operates natural gas compression equipment; and crude oil and n …
  • Dollarama Inc:戦略・SWOT・企業財務分析
    Dollarama Inc - Strategy, SWOT and Corporate Finance Report Summary Dollarama Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Wind Direct Ltd:電力:M&Aディール及び事業提携情報
    Summary Wind Direct Ltd (Wind Direct) a subsidiary of Infinite Renewables Ltd is a renewable energy company that installs and operates industrial wind turbines. The company’s services include feasibility studies, wind turbine installation, and operation services. It offers consulting services to che …
  • Maersk Tankers AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Maersk Tankers AS (Maersk Tankers), a subsidiary of A.P. Moeller Holding AS is an oil and gas company that offers energy transportation services through oil tankers. The company provides services such as crude oil and refined oil transportation, warehousing and distribution, supply chain man …
  • genedrive plc (GDR):企業の財務・戦略的SWOT分析
    genedrive plc (GDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Chiyoda Corp (6366):企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • NanoSmart Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary NanoSmart Pharmaceuticals Inc (NanoSmart) focuses on the development of novel methods for the treatment of cancer and other diseases. The company is evaluating a human-derived anti-nuclear antibody which targets areas of necrosis presence in various different types of cancer tumors. Its prop …
  • Ansaldo Energia SpA:電力:M&Aディール及び事業提携情報
    Summary Ansaldo Energia SpA (Ansaldo Energia), a subsidiary of CDP Equity SpA, is a power generation company and a supplier of power plant equipment and related services. It provides power plant equipment such as gas turbines, steam turbines, turbo generators, and hydro-generators used in fossil fue …
  • PriceSmart, Inc. (PSMT):企業の財務・戦略的SWOT分析
    PriceSmart, Inc. (PSMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • BioCryst Pharmaceuticals Inc (BCRX):企業の財務・戦略的SWOT分析
    BioCryst Pharmaceuticals Inc (BCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Philippine National Bank:企業の戦略・SWOT・財務分析
    Philippine National Bank - Strategy, SWOT and Corporate Finance Report Summary Philippine National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pioneer Natural Resources Company:企業のM&A・事業提携・投資動向
    Pioneer Natural Resources Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pioneer Natural Resources Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Chesapeake Lodging Trust:企業のM&A・事業提携・投資動向
    Chesapeake Lodging Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chesapeake Lodging Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • TherOx Inc:医療機器:M&Aディール及び事業提携情報
    Summary TherOx Inc (TherOx) is a medical device company that develops and commercializes SuperSaturated Oxygen (SSO2) therapies for treatment of heart attack. Its SSO2 therapy is designed to ameliorate progressive myocardial necrosis by minimizing microvascular damage in heart attack patients. TherO …
  • Del Frisco’s Restaurant Group, Inc.:企業の戦略・SWOT・財務情報
    Del Frisco’s Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Frisco’s Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Tabuk Pharmaceuticals Manufacturing Company-製薬・医療分野:企業M&A・提携分析
    Summary Tabuk Pharmaceuticals Manufacturing Company (Tabuk), a subsidiary of Astra Industrial Group is a drug company that develops, manufactures and markets branded generic pharmaceuticals and under-licensed products . The company offers products in various therapeutic areas including alimentary tr …
  • Biotest AG (BIO):企業の財務・戦略的SWOT分析
    Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Southern Minnesota Municipal Power Agency:企業の発電所・SWOT分析2018
    Southern Minnesota Municipal Power Agency - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inform …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆